Skip to main content
Archana Mishra Agarwal, MD
Medical Director, Hematopathology and Special Hematology
Professor (Clinical), University of Utah School of Medicine
Specialties
Hematopathology
RBC membrane and enzyme disorders
Hemoglobinopathies/thalassemia
Molecular hematology
Education
Medical Degree—Assam Medical College, India
Residency—Anatomic and Clinical Pathology, University of Utah School of Medicine
Fellowship—Hematopathology, University of Utah School of Medicine
Fellowship—Molecular Genetic Pathology, University of Utah School of Medicine
Certification/Affiliations
American Board of Pathology (Anatomic Pathology and Clinical Pathology, Hematology, Molecular Genetic Pathology)
Research Interests
Red cell enzymopathies
Hemoglobinopathies
Molecular hematopathology
Recent Publications
Gorfinkel L, et al. Transient neonatal hemolytic anemia due to the novel gamma globin gene mutation HBG2:C.290T>C, p.Leu97Pro (hemoglobin Wareham) . Pediatr Blood Cancer . 2023;70(1):e30067.
Lin Y, et al. Characterization of structural hemoglobin variants by top-down mass spectrometry and R programming tools for rapid identification . J Am Soc Mass Spectrom . 2022;33(1):123–130.
Montgomery HD, et al. A case of azathioprine-induced aplastic anemia . Int J Lab Hematol . 2022;44(6):1015–16.
Agarwal AM, et al. Laboratory approach to investigation of anemia in pregnancy . Int J Lab Hematol . 2021;43 Suppl 1:65–70.
Lozano-Chinga M, et al. Bone marrow necrosis in pediatric malignancies: 10-year retrospective review and review of literature . Pediatr Blood Cancer . 2021;68(3):e28806.
Cowman SJ, et al. Correction: Macrophage HIF-1α is an independent prognostic indicator in kidney cancer . Clin Cancer Res . 2021 Jun 1;27(11):3265.
Pond GR, et al. Clinical outcomes of platinum-ineligible patients with advanced urothelial carcinoma treated with first-line PD1/L1 inhibitors . Clin Genitourin Cancer . 2021;19(5):425–33.
Bahr TM, et al. Thirty-five males with severe (class 1) G6PD deficiency (c.637G>T) in a North American family of European ancestry . Blood Cells Mol Dis . 2021;92:102625.
Bahr TM, et al. Does heterozygosity for UGT1A1 *28 convey increased risk for severe neonatal jaundice? J Perinatol . 2021;41(4):658–60.
Iglesias Cardenas F, et al. Two clonally distinct B-cell lymphomas reveal the diagnosis of XLP1 in a male child and his asymptomatic male relatives: case report and review of the literature . J Pediatr Hematol Oncol . 2021;43(8):e1210–e1213.
Maglic D, et al. A case report of misdiagnosed breast implant-associated anaplastic large cell lymphoma with lymphatic extension . Plast Reconstr Surg Glob Open . 2021;9(11):e3916.
Kim SJ, et al. Novel mechanism of hereditary pyropoikilocytosis phenotype due to co-inheritance of β globin and α spectrin mutations . Am J Hematol . 2021;96(5):E150–E154.
Bahr TM, et al. Infantile pyknocytosis: end-tidal CO, %micro-R measurements, next-generation sequencing, and transfusion avoidance with darbepoetin . Biomed Hub . 2020;5(3):227–34.
Meznarich JA, et al. Novel, de novo, beta-globin variant with decreased oxygen affinity (HBB:c.317T>A, "hemoglobin St. George") in a healthy child with low oxygen saturations and anemia . Am J Hematol . 2021;96(12):E448–E450.
Bahr TM, et al. A novel variant in G6PD (c.1375C>G) identified from a Hispanic neonate with extreme hyperbilirubinemia and low G6PD enzymatic activity . Neonatology . 2020;117(4):532–5.
Bahr TM, et al. Dizygotic twins with prolonged jaundice and microcytic, hypochromic, hemolytic anemia with pyropoikilocytosis . Blood Cells Mol Dis . 2020;85:102462.
Samha L, et al. Molecular understanding of severe cases of β-thalassemia in the Nablus region, West Bank, Palestine . Hemoglobin . 2020;44(2):128–30.
Rets AV, et al. δ-globin chain variants associated with decreased Hb A2 levels: a national reference laboratory experience . Hemoglobin . 2020;44(6):438–41.
Agarwal AM, et al. Laboratory approach to investigation of anemia with a focus on pyruvate kinase deficiency . Int J Lab Hematol . 2020;42 Suppl 1:107–12.
He L, et al. Top-down proteomics—a near-future technique for clinical diagnosis? Ann Transl Med . 2020;8(4):136.
Cowman SJ, et al. Macrophage HIF-1α is an independent prognostic indicator in kidney cancer . Clin Cancer Res . 2020;26(18):4970–82.
Stenehjem DD, et al. Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma . PLoS One . 2019;14(1):e0210415.
Patel AB, et al. JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera . Blood . 2019;134(26):2388–98.
Agarwal A, et al. A new subtyping model for residual invasive disease after cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer . Transl Androl Urol . 2019;8(Suppl 3):S254–S256.
He L, et al. Diagnosis of hemoglobinopathy and β-thalassemia by 21 tesla fourier transform ion cyclotron resonance MS and MS/MS of hemoglobin from blood . Clin Chem . 2019;65(8):986–94. Epub.
Rets A, et al. Molecular diagnostic update in hereditary hemolytic anemia and neonatal hyperbilirubinemia . Int J Lab Hematol . 2019.; 41(Suppl 1):95–101.
Bahr TM, et al. The Neonatal Acute Bilirubin Encephalopathy Registry (NABER): background, aims, and protocol . Neonatology . 2019;115(3):242–6.
Archana M Agarwal. Ankyrin mutations in hereditary spherocytosis . Commentary. Acta Haematologica. 2019;141(2):63–4.
Polega J, et al. Novel mutation in spta1 gene associated with severe hemolytic anemia . J Pediatr Neonatal Care. 2018;8(5):250–3.
Bianchi P, et al. addressing the diagnostic gaps in pyruvate kinase (pk) deficiency: consensus recommendation on the diagnosis of PK deficiency . Am J Hematol. 2019;94(1):149–61.
Christensen RD, et al. Acute neonatal bilirubin encephalopathy in the State of Utah 2009-2018 . Blood Cells Mol Dis . 2018;72:10–3.
Christensen RD, et al. Three novel spectrin variants in jaundiced neonates . Clin Pediatr (Phila). 2018;57(1):19–26
Bailey EB, et al. Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors . J Oncol Pharm Pract . 2018;24(3):190–7.